| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | 4 | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 0.95 |
—
—
|
| 2024 | 0.00 |
—
—
|
| 2023 | 0.80 |
—
—
|
| 2022 | 0.75 |
—
—
|
| 2021 | 0.70 |
—
—
|
| 2020 | 0.00 |
—
—
|
| 2019 | 0.60 |
—
—
|
| 2018 | 0.55 |
—
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 1.95 | 0.48 | 0.59 | 1.15 |
| Receivables | 72.73 | 84.96 | 76.66 | 84.31 |
| Inventory | 172.94 | 196.56 | 254.60 | 245.83 |
| Other | 6.81 | — | — | — |
| 254.43 | 294.09 | 346.42 | 349.31 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 42.68 | 53.44 | 60.48 | 72.44 |
| ST’ Debt | 0.96 | 21.70 | 58.82 | 39.90 |
| Other | 40.32 | — | — | — |
| 85.69 | 125.94 | 156.05 | 167.93 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 298.68 | 314.78 | 281.78 | 280.43 |
1,175.67
|
| ’25 | 276.20 | 301.07 | 260.91 | 269.08 |
1,107.25
|
| ’24 | 234.11 | 291.22 | 271.88 | 269.57 |
1,066.78
|
| ’23 | 252.60 | 274.33 | 238.54 | 234.22 |
999.69
|
| ’22 | 226.33 | 253.21 | 218.58 | 257.75 |
955.87
|
| ’21 | 210.27 | 233.58 | 207.89 | 206.74 |
858.48
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 32.13 | 62.49 | 0.20 | 29.02 |
123.84
|
| ’25 | 8.93 | 10.98 | (25.90) | 36.53 |
30.55
|
| ’24 | 21.88 | 39.29 | 5.27 | 35.24 |
101.67
|
| ’23 | 30.65 | 40.31 | 1.44 | 52.27 |
124.66
|
| ’22 | 0.90 | 14.92 | (28.37) | 32.16 |
19.60
|
| ’21 | 20.58 | 41.36 | 15.09 | 27.67 |
104.70
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 7.26 | 40.05 | (21.47) | 9.91 |
35.75
|
| ’25 | (2.97) | (2.67) | (37.58) | 23.05 |
(20.17)
|
| ’24 | 15.89 | 34.40 | (1.32) | 24.39 |
73.36
|
| ’23 | 24.73 | 34.80 | (2.73) | 47.12 |
103.92
|
| ’22 | (0.26) | 10.55 | (31.73) | 27.24 |
5.80
|
| ’21 | 14.55 | 36.56 | 10.45 | 18.26 |
79.82
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 1.59 | 1.53 | 1.43 | 0.71 |
5.26
|
| ’25 | 1.00 | 1.16 | 1.72 | 1.15 |
5.03
|
| ’24 | 1.51 | 1.64 | 1.15 | 0.86 |
5.15
|
| ’23 | 1.34 | 1.45 | 1.35 | 1.26 |
5.40
|
| ’22 | 1.66 | 1.14 | 1.02 | 1.50 |
5.33
|
| ’21 | 1.11 | 1.72 | 1.27 | 1.07 |
5.17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 67.02 | 76.49 | 79.07 | 58.47 | 67.42 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 92.10 | 127.26 | 108.96 | 91.26 | 92.08 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,300 | 1,400 | 1,800 | 1,900 | 1,770 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.74 | 0.71 | 0.59 | 0.58 | 0.66 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 955.87 | 999.69 | 1,066.78 | 1,107.25 | 1,175.67 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.88% | 21.17% | 20.07% | 18.38% | 17.96% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 81.70 | 85.35 | 79.94 | 77.87 | 82.98 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.55% | 8.54% | 7.49% | 7.03% | 7.06% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.79 | 62.86 | 60.25 | 58.93 | 61.93 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.71 | 22.14 | 26.60 | 31.47 | 33.30 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 82.85 | 86.35 | 91.85 | 94.99 | 100.49 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.36 | 5.43 | 5.19 | 5.06 | 5.29 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.70 | 10.77 | 8.75 | 2.62 | 10.59 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.20) | (1.79) | (2.44) | (4.35) | (7.53) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 0.50 | 8.98 | 6.32 | (1.73) | 3.06 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.17 | 25.24 | 27.78 | 30.95 | 32.48 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.54 | 11.58 | 11.62 | 11.66 | 11.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.52 | 21.56 | 18.47 | 12.50 | 16.22 | ‡‡‡‡ | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.88 | 1.36 | 1.04 | 0.67 | 0.86 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.00 | 4.65 | 3.45 | 2.04 | 2.65 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.93 | 1.36 | 1.07 | 0.73 | 0.93 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 153.03 | 13.12 | 15.55 | (40.16) | 30.44 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.60 | 124.66 | 101.67 | 30.55 | 123.84 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (13.80) | (20.73) | (28.31) | (50.71) | (88.09) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.80 | 103.92 | 73.36 | (20.17) | 35.75 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 160.40 | 168.74 | 168.15 | 190.38 | 181.38 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.58 | 8.06 | 28.07 | 73.38 | 83.47 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.16 | 6.11 | 27.58 | 72.80 | 82.32 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 278.82 | 292.21 | 322.61 | 360.70 | 379.95 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.61% | 14.41% | 12.81% | 10.59% | 9.86% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.56% | 18.90% | 15.20% | 12.21% | 12.06% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.70% | 22.02% | 19.60% | 17.25% | 16.72% | — | — | — |
ROE
|
John B. Sanfilippo & Son, Inc. (JBSS), a reliable player in processed nuts and snacks under brands like Fisher and Orchard Valley Harvest, has delivered steady performance with resilient revenue growth from $952 million in 2016 to $1.067 billion in 2024 (1.5% CAGR), fueled by private-label and branded volumes despite commodity volatility in almonds and pecans. Profitability shines through robust ROE (17.3% projected for 2025) and ROIC, with net income up 100% over the decade, though recent margin compression (gross margins down to 20.1%) and free cash flow swings—from peaks of $125 million OCF to projected negatives—signal caution amid rising capex and headcount.
The balance sheet remains a fortress, with equity up 44% to $361 million and low leverage (net debt/equity <20%), providing downside protection in a cyclical industry. Valuation looks compelling at 12.5x forward PE and 0.67x PS, trading at a discount to highs despite resilient stock lows, hinting at mean reversion potential if efficiencies materialize.
Analysts project 3-4% revenue CAGR through 2027 with EPS surging 31% to $7.31 on margin recovery, implying 36% upside—but risks from FCF volatility, productivity dips, and harvest shocks loom large. JBSS suits conservative holds for 8-12% returns, yet fresh buys warrant watching capex yields and commodity stability.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.